Contact
Please use this form to send email to PR contact of this press release:
Zynerba Pharmaceuticals Announces ZYN002 Granted Orphan Drug Designation for Fragile X Syndrome
TO:
Please use this form to send email to PR contact of this press release:
Zynerba Pharmaceuticals Announces ZYN002 Granted Orphan Drug Designation for Fragile X Syndrome
TO: